Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
US8846699B2 · kind B2 · utility
1Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2006 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | May 7, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel quinazoline derivative compound having the formula (1) as follows:with the constituents defined in claim 1, and a pharmaceutically acceptable salt thereof as a multiplex inhibitor, a method for the preparation thereof, and a pharmaceutical composition and a therapeutic composition comprising same as an active ingredient. The inventive quinazoline derivative as a multiplex inhibitor can selectively and effectively inhibit diseases caused by the overactivity of a tyrosine kinase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.